HUP0402524A2 - Venlafaxin-hidroklorid kristályos polimorf formája, eljárások előállítására, az ezt tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents

Venlafaxin-hidroklorid kristályos polimorf formája, eljárások előállítására, az ezt tartalmazó gyógyszerkészítmények és alkalmazásuk

Info

Publication number
HUP0402524A2
HUP0402524A2 HU0402524A HUP0402524A HUP0402524A2 HU P0402524 A2 HUP0402524 A2 HU P0402524A2 HU 0402524 A HU0402524 A HU 0402524A HU P0402524 A HUP0402524 A HU P0402524A HU P0402524 A2 HUP0402524 A2 HU P0402524A2
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
crystalline polymorph
venlafaxine hydrochloride
Prior art date
Application number
HU0402524A
Other languages
English (en)
Inventor
Kadum Abdul Nabi Ali
Jun Han
Yong Jai Lee
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Publication of HUP0402524A2 publication Critical patent/HUP0402524A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya termikusan stabil, vízmentes venlafaxin--hidroklorid kristályos polimorf formája, a vegyületek előállítása ésalkalmazása. A venlafaxin ismert antidepresszáns. Ó
HU0402524A 2001-12-05 2002-12-03 Venlafaxin-hidroklorid kristályos polimorf formája, eljárások előállítására, az ezt tartalmazó gyógyszerkészítmények és alkalmazásuk HUP0402524A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33582201P 2001-12-05 2001-12-05
PCT/US2002/038401 WO2003050075A1 (en) 2001-12-05 2002-12-03 Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
HUP0402524A2 true HUP0402524A2 (hu) 2005-03-29

Family

ID=23313356

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402524A HUP0402524A2 (hu) 2001-12-05 2002-12-03 Venlafaxin-hidroklorid kristályos polimorf formája, eljárások előállítására, az ezt tartalmazó gyógyszerkészítmények és alkalmazásuk

Country Status (21)

Country Link
US (2) US7030164B2 (hu)
EP (1) EP1451145A1 (hu)
JP (1) JP2005511736A (hu)
KR (1) KR20050044673A (hu)
CN (1) CN1630631A (hu)
AR (1) AR037744A1 (hu)
AU (1) AU2002348266A1 (hu)
BR (1) BR0214742A (hu)
CA (1) CA2467593A1 (hu)
CO (1) CO5580818A2 (hu)
EC (1) ECSP045136A (hu)
HU (1) HUP0402524A2 (hu)
IL (1) IL162255A0 (hu)
MX (1) MXPA04005305A (hu)
NO (1) NO20042681L (hu)
NZ (1) NZ533363A (hu)
PL (1) PL370552A1 (hu)
RU (1) RU2004120285A (hu)
TW (1) TW200301101A (hu)
WO (1) WO2003050075A1 (hu)
ZA (1) ZA200405248B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
EP1330427A1 (en) * 2000-10-31 2003-07-30 Ciba SC Holding AG Crystalline forms of venlafaxine hydrochloride
CN101014337A (zh) * 2004-07-22 2007-08-08 惠氏公司 治疗神经系统障碍和病症的方法
EP1773321A2 (en) * 2004-07-22 2007-04-18 Wyeth Method for treating nervous system disorders and conditions
CA2574310A1 (en) * 2004-07-22 2006-02-02 Wyeth Method for treating nervous system disorders and conditions
US20070021488A1 (en) * 2005-07-21 2007-01-25 Wyeth Method for treating nervous system disorders and conditions
JP2009511641A (ja) * 2005-10-19 2009-03-19 テバ ファーマシューティカル インダストリーズ リミティド 高純度１−〔２−ジメチルアミノ−（４−メトキシフェニル）エチル〕シクロヘキサノール塩酸塩の調製方法
ES2609264T3 (es) * 2007-02-21 2017-04-19 Sepracor Inc. Formas sólidas que comprenden (-)-O-desmetilvenlafaxina y usos de las mismas
DK2621891T3 (da) * 2010-10-01 2020-02-17 Shan Dong Luye Pharm Co Ltd Polymorfer af 4-[2-dimethylamino-1-(1 hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoathydrochlorid, fremgangsmåder til fremstilling og anvendelse deraf
US9346800B2 (en) 2012-09-18 2016-05-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
KR20240049625A (ko) 2015-03-06 2024-04-16 오스펙스 파마슈티칼스, 인코포레이티드 비정상적 불수의 운동 장애의 치료 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
EP1738753B1 (en) * 1993-06-28 2008-04-23 Wyeth New treatments using phenethylamine derivatives
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US20020143211A1 (en) 2000-10-19 2002-10-03 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochlorid, processes for preparing thereof
EP1330427A1 (en) 2000-10-31 2003-07-30 Ciba SC Holding AG Crystalline forms of venlafaxine hydrochloride
AU2001235970A1 (en) 2000-12-07 2002-06-18 Dr. Reddy's Research Foundation Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)

Also Published As

Publication number Publication date
CO5580818A2 (es) 2005-11-30
NO20042681L (no) 2004-06-25
EP1451145A1 (en) 2004-09-01
US20060074131A1 (en) 2006-04-06
US20030109585A1 (en) 2003-06-12
US7030164B2 (en) 2006-04-18
NZ533363A (en) 2005-10-28
ZA200405248B (en) 2005-10-03
KR20050044673A (ko) 2005-05-12
CA2467593A1 (en) 2003-06-19
MXPA04005305A (es) 2004-09-13
IL162255A0 (en) 2005-11-20
JP2005511736A (ja) 2005-04-28
BR0214742A (pt) 2004-09-14
AU2002348266A1 (en) 2003-06-23
PL370552A1 (en) 2005-05-30
CN1630631A (zh) 2005-06-22
ECSP045136A (es) 2004-07-23
RU2004120285A (ru) 2005-04-10
AR037744A1 (es) 2004-12-01
WO2003050075A1 (en) 2003-06-19
TW200301101A (en) 2003-07-01

Similar Documents

Publication Publication Date Title
BR0213931A (pt) Forma polimórfica de rimonabant, processo para sua preparação e composições farmacêuticas contendo-as
HUP0303128A2 (hu) O-dezmetil-venlafaxin új szukcinátsója, eljárás az előállításukra, alkalmazása és ezt tartalmazó gyógyszerkészítmény
GEP20074133B (en) New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
ATE450497T1 (de) Formoteroltartrat verfahren und polymorph
NO20040794L (no) (-)-1-(3,4-Diklorfenyl)-3-azabicyklo[3.1.0]heksan, forbindelser derav og anvendelser som en dopamin-gjenopptaks-inhibitor.
HUP0400343A2 (hu) Ciklopropil-indol-származékok mint szelektív szerotonin-újrafelvétel inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0302519A2 (hu) Az atorvasztatin kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20052676L (no) Polymorfer av bicifadin-saltsyre
TW200510277A (en) Crystalline form of β2-adrenergic receptor agonist
HUP0402524A2 (hu) Venlafaxin-hidroklorid kristályos polimorf formája, eljárások előállítására, az ezt tartalmazó gyógyszerkészítmények és alkalmazásuk
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
NO20071372L (no) Nye polymorfer av azabisykloheksan
TNSN04024A1 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
UY27287A1 (es) Sal citrato de 5,8,14-triazatetraciclo[10.3.1.0 2,11.0 4,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma
ECSP066564A (es) Formulaciones de tableta de liberación extendida de venlafaxina
HUP0402553A2 (hu) Venlafaxin-hidroklorid-monohidrát, eljárások előállítására, az ezt tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0303341A2 (hu) Monoamin-felvétel inhibitora és ezt tartalmazó gyógyszerkészítmények
HUP0402535A2 (hu) RSV fúzió inhibitor hatású imidazo-piridin-vegyület dihidroklorid-monohidrát sója és az ezt tartalmazó gyógyszerkészítmények
NO20055495L (no) 4-(4-trans-hydroksysykloheksyl)amino-2-fenyl-7H-pyrrolo[2,3-d]-pyrimidinhydrogenmesylat og dets polymorfe former
HUP0303174A2 (hu) A terbinafin almasav addíciós sói, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0401895A2 (hu) Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
EP1406614A4 (en) CARVEDILOLPOLYMORPH
BR0315348A (pt) Processo para a preparação de um composto, e composto
HUP0204401A2 (hu) Eljárás 2,6-diklórfenol-vegyületek előállítására

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees